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Public Willingness to Participate in and Public Opinions About 
Genetic Variation Research: A Review of the Literature 
| Rene Sterling, MHA, Gail E. Henderson, PhD, and Giselle Corbie-Smith, MD, MSScientists are turning to
genetic variation research in
hopes of addressing persis-
tent racial/ethnic disparities
in health. Despite ongoing
controversy, the advance-
ment of genetic variation re-
search is likely to produce
new knowledge and tech-
nologies that will substan-
tially change the ways in
which we understand and
value health. They also may
affect the ways in which in-
dividuals and groups orga-
nize socially, politically, and
economically. 
Addressing concerns that
may exist in different com-
munities is vital to the scien-
tific and ethical advancement
of genetic variation research.
We review empirical studies
of public willingness to par-
ticipate in and opinions about
genetic research with partic-
ular attention to differences
in consent and opinion by ra-
cial/ethnic group member-




described the integration of new
genetic knowledge and technolo-
gies into the practice of public
health and medicine as unavoid-
able.1 Newborn screening pro-
grams, prenatal testing, and ge-
nealogy documentation provide
long-standing precedent for this
integration. Scientists now are
turning to research that seeks to
understand genetic differences
by racial/ethnic group member-
ship (referred to as genetic varia-




the lack of definitional clarity
and inconsistent use of racial/
ethnic group membership in US
health research,2 while at the
same time depending on these
categories to define and explain
disparities in health and health
care.3 These categories gener-
ally include 1 or more of the
categories used by the federal
government, namely an ethnic
group category—Hispanic/
Latino—and several racial group
categories—White American/
White, African American/Black,
Asian American, Native Hawaiian/
Other Pacific Islander, and Amer-
ican Indian/Alaska Native—in
addition to Other and more 
recently Mixed Race.
The proposed use of racial/
ethnic group membership in ge-
netic variation research has been
widely debated. Advocates argue
that significant genetic differences
do exist by racial/ethnic group
membership and that such infor-
mation is critical to ensuring
representative sampling.4,5 Advo-
cates also propose that genetic
variation research may lead to
health benefits, such as improved
understanding of disease suscepti-
bility and targeted pharmacoge-
nomic innovations.6,7 Critics raise
methodological concerns about
the validity of racial/ethnic group
membership for studying genetic
variation.8–10 Furthermore, critics
assert that such research may en-
courage genetic determinism and
scientific racism, divert attention
from the powerful social and envi-
ronmental determinants of health,
and reinforce stereotypes about
minority groups.10–12
Despite ongoing controversy,
the trajectories of genetic varia-
tion research are likely to produce
new knowledge and technologies
that will substantially change the
ways in which we understand and
value health. They also may affect
the ways in which individuals and
groups are organized socially, po-
litically, and economically in soci-
ety.13 Given this potential, strong
arguments have been made in the
literature for public consultation
regarding the advancement of
genetic science.13–15 Consultation
with racial/ethnic minority groups
is particularly important given
these groups’ past experience with
the misuse of science. Addressing
concerns that may exist in differ-
ent communities is fundamental
to the ethical advancement of ge-
netic variation research and may
facilitate the recruitment of di-
verse samples that are vital to an-
swering the underlying scientific
questions posed by genetic varia-
tion research.
What is known about the
willingness of the public to par-
ticipate in genetic variation re-
search? Does willingness to
participate in genetic variation
research vary by racial/ethnic
group membership? What con-
cerns and other opinions do peo-
ple have about genetic variation
research? We present findings
from a systematic review of em-
pirical studies regarding US pub-
lic willingness to participate in
and opinions about genetic varia-
tion research and other genetic




searches for empirical studies of
public willingness to participate
in and opinions about genetic
variation research in the Na-
tional Library of Medicine Med-
line database and all databases
under the Institute of Scientific
Information Web of Science.
Given limited results, we estab-
lished broader parameters for
a larger search using general
search terms and including stud-
ies involving genetic research re-
gardless of an explicit focus on
variation by racial/ethnic group
(Table 1). We excluded genetic
research studies that referenced
genetic testing (i.e., detection of
specific genes or gene variants
in individuals rather than in
populations) but did not refer-
ence the donation or storage of
genetic specimens for research
(example16). Unlike the purpose
and results of research involving
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TABLE 1—Search Strategy for Empirical Papers Regarding Public Opinions About and Willingness to
Participate in Genetic Research: July–August 2005
Medlinea ISI Web of Scienceb
Search Relevant Search Relevant 
Keywords and Boolean terms Results Papersc Results Papers
Geneti* AND [Racial OR Race OR Ethnicity] AND Attitud* 279 7 50 3
Geneti* AND [Racial OR Race OR Ethnicity] AND Awar* 132 0 41 0
Geneti* AND [Racial OR Race OR Ethnicity] AND Consent 120 5 22 5
Geneti* AND [Racial OR Race OR Ethnicity] AND Inten* 290 1 90 1
Geneti* AND [Racial OR Race OR Ethnicity] AND Knowledge 472 2 130 0
Geneti* AND [Racial OR Race OR Ethnicity] AND Opinio* 50 4 13 1
Geneti* AND [Racial OR Race OR Ethnicity] AND Participat* 433 13 77 8
Geneti* AND [Racial OR Race OR Ethnicity] AND Perspectiv* 146 2 73 2
Geneti* AND [Racial OR Race OR Ethnicity] AND Willin* 30 3 10 1
Genom* AND [Racial OR Race OR Ethnicity] AND Attitud* 14 2 5 1
Genom* AND [Racial OR Race OR Ethnicity] AND Awar* 4 0 2 0
Genom* AND [Racial OR Race OR Ethnicity] AND Consent 23 0 4 0
Genom* AND [Racial OR Race OR Ethnicity] AND Inten* 27 0 22 0
Genom* AND [Racial OR Race OR Ethnicity] AND Knowledge 56 1 31 0
Genom* AND [Racial OR Race OR Ethnicity] AND Opinio* 2 1 1 0
Genom* AND [Racial OR Race OR Ethnicity] AND Participat* 28 3 17 0
Genom* AND [Racial OR Race OR Ethnicity] AND Perspectiv* 19 1 12 1
Genom* AND [Racial OR Race OR Ethnicity] AND Willin* 1 1 0 0
Totald 2126 46 600 23
Note. ISI = Institute of Scientific Information.
aSearch for keywords in all fields of document with human subjects, in English language, and not a letter, comment, editorial, or news (i.e., NOT
letter[pt] NOT comment[pt] NOT and so on, where [pt] stands for publication type), published 1985 to 2005.
bSearch for keywords as topic (TS field tag) in all document types, English language, published 1985 to 2005, in all 3 Web of Science databases.
cRelevant papers selected after 2 stages of review: (1) title and abstract review and (2) full paper review of those selected in first stage.
dDuplicate papers included in totals. Nonduplicate totals in both Medline and ISI search results=1793 papers, 13 relevant papers.
genetic testing, the purpose and
results of research involving
specimen donation may not be
shared with human subjects,
particularly in the case of long-
term storage. Furthermore, re-
search involving specimen dona-
tion is less likely to offer human
subjects the direct and immedi-
ate benefits associated with re-
search involving genetic testing,
such as test results, medical
treatment, or other interven-
tions. Therefore, findings from
these 2 types of studies are not
comparable.
We conducted systematic
searches of the Medline and
Institute of Scientific Information
Web of Science databases during
July and August 2005 using the
parameters specified in Table 1.
Search results, citations, and
available abstracts for 2126 pa-
pers were downloaded into a ci-
tation database for review and
tracking. Two authors reviewed
titles and available abstracts. The
vast majority of papers presented
findings from gene prevalence
studies in various populations.
Thirty-three papers were selected
as potentially relevant by at least
1 of the 2 authors during this ini-
tial review. Twenty papers were
excluded because they were not
empirical studies on willingness
to participate in or opinions
about genetic research (13 stud-
ies), they involved international
populations (5 studies), or they
were published only as abstracts
(2 studies). Thirteen papers were
determined to be relevant after
full-text review. 
Reference lists from the 13
relevant papers were reviewed
for additional papers that may
not have been captured by the
database searches. Twenty-eight
papers were identified in refer-
ence lists as potentially relevant,
1 of which was determined to be
relevant after abstract or full-text
review.17
Among the 14 relevant
studies, 1 did involve genetic
testing18 and was included be-
cause participants were in-
formed that they would not
receive test results and also
were asked for consent to store
DNA—2 features more typical of
research involving genetic speci-
men donation. Finally, 1 rele-
vant article identified in the pre-
liminary search did not appear
in the systematic search and
therefore was not included in
this review.19 This article did not
use the terms race, ethnicity, or
any variation (excluding 1 ap-
pearance of race in a table), nor
did it have these terms assigned
as keywords.
Findings from the reviewed
studies are presented in 3 tables:
Table 2, studies reporting willing-
ness to participate only; Table 3,
studies reporting willingness to
participate and reasons for de-
clining; and Table 4, studies re-
porting opinions only. Study ref-
erence numbers appear in the
tables and are used to discuss
review findings.
RESULTS
Our literature search pro-
duced 14 empirical studies on
willingness to participate in and
opinions about genetic research.
Only 1 of these 14 studies
made clear references to genetic
variation research exploring re-
lations among race, genes, and
health.29 The purpose of most
studies (10 studies) was to mea-
sure consent rates in response
to requests for participation in
genetic research (Tables 2 and
3). Three of these 10 studies
asked participants why they de-
clined consent (Table 3), with 2
providing frequencies for re-
ported reasons.18,26 Additional
detail regarding participants’
concerns was described in 4
qualitative studies (Table 4). Fi-
nally, 8 of the 14 studies asked
participants to consider specific
information regarding the use of
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TABLE 2—Descriptive Summary of Studies Regarding US Lay Public Willingness to Participate in 
Genetic Research (n=7)
Consent to Less 
Author Year Purpose Sample Methods Participation in Research Likely to Consent
Cozier et al. Compare consent to genetic National (n = 644) 2, 3, 7, 11 37% of total sample Not reported
200420 research and DNA yield Former Black female health 
for different specimen research participants with 
collection methods personal history of cancer
Some college/higher 80%
Le Marchand Assess feasibility of obtaining Hawaii (n = 355) 1, 3, 7, 10, 11 67% of total sample Hawaiians
et al. DNA by mail for Current cohort study participants
200117 analysis and storage Whites 34%, Japanese 33%,
Hawaiian 33%
McQuillan et al. Identify factors associated National (2-y mean n = 3201) 1, 3, 5, 7, 9 85% of total sample (2-y mean, Blacks,b females, older age
200321 with consent to donate NHANES study participants 100% responding)
and store specimens White 47%, Mexican American 
23%, Black 20%, Other 10%
Moorman et al. Identify factors associated North Carolina (n = 872) 2, 3, 7, 10, 11 28% of total sample, 47% of Blacks,a b older age,a b lower 
200422 with consent to enroll in Former female genetic research responders (n = 469) income,a less education,a
cancer genetics registry participants higher occupation category,a
Personal or familial history of later- stage first cancer 
various cancers diagnosis (among Blacks only),b
White 59%, Black 41% higher body mass index,a
College grad 30% higher waist-to-hip ratioa
Ottoman et al. Identify factors associated New York (n = 320 families) 2, 3, 7, 8, 21% of total sample, 26% of Recruited in specialty clinic,a initial 
200523 with consent to enroll in White 51%, Other 28%, 10, 11, 12 responders (n = 232), 54% contact by letter,a males, racial/
epilepsy genetic research Unknown 21% of eligible families (n = 126), ethnic minority,a relatives of 
79% of individuals within affected participant
eligible families 
(n = not reported)
Schwartz et al. Measure willingness to donate Maryland, District of Columbia 2, 3, 6 Physical/mental health genetic Weaker Jewish cultural identity,a when 
200124 and store blood (n = 273) research: 85%–90% of total DNA is collected in research 
specimens and the need Jewish sample settings (vs clinical settings), in 
for informed consent College or higher 87% Creativity/intelligence genetic studies identifying stigmatizing 
research: 70%–85% of traits (including frugality,
total sample homosexuality)a
Stigmatizing trait genetic research: 
60%–75% of total sample
Wang et al. Measure opinions and National (n = 2621) 1, 4, 6 Donate: 53% of total sample Racial/ethnic minority,a older age,a
200125 willingness to donate and Whites 83%, Black or Donate and store: 43% less education,a no family 
store blood specimens Hispanic 17% of total sample history,a low-risk lifestyle,a b low 
College or higher 60% Will not donate or store: support of government research,b
Family history genetic 21% of total sample no belief in medical benefit of 
condition 12% genetic research,b no belief in 
genetic determinismb
Note. Table presents 7 of 14 total studies identified in literature search. Methods: 1 = random sampling; 2 = nonrandom sampling; 3 = primary data collection; 4 = secondary data analysis;
5 = household specimen collection; 6 = individual phone/self-administered survey; 7 = actual request; 8 = health care setting/physician request; 9 = in-person request; 10 = telephone
request/follow-up; 11 = mailed request; 12 = Web site request.
aStatistically significant in multivariate regression analysis (α = .05).
bStatistically significant association found with willingness/consent in bivariate or stratified analysis (α = .05).
their DNA,18,22–24,26,27 or a




There was limited racial/
ethnic group diversity across
studies; however, all studies
included 1 or more racial/
ethnic minority groups. African
Americans constituted the en-
tire sample of 3 studies,20,27,30
and Jews the entire sample of 1.24
Asian Americans and Native
Hawaiians/Other Pacific Island-
ers were least represented,17,26,29
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TABLE 3—Descriptive Summary of Studies Regarding US Lay Public Willingness to Participate in Genetic 
Research and Reasons for Declining Consent (n=3)
Consent to 
Author Year Purpose Sample Methods Participation In Research Less Likely to Consent Reasons for Declinea
Audrain et al. Establish longitudinal cohort Virginia (n = 2120) 1, 2, 4, 7, 8 54% of parents in total sample, Nonsmokers,c less education,c No interest 47%,
200226 for study of genetic and Parents of eligible 75% of parent responders racial/ethnic minority,c confidentiality 16%,
other factors associated teens (n = 1533), 99% of teens Whites with less educationd no time 10%, teen 
with teen smoking Responders onlyb: with parental consent doesn’t smoke 10%,







Bogner et al. Identify factors associated Maryland 1, 2, 3, 4, 5 Genotyping: 9% of total sample, Genotyping and storage given Genotyping: 
200418 with willingness to (n = 3459) 88% of eligible responders genotyping: older age,c d confidentiality 22%,
participate in genotyping Current mental (n = 342) Blackc d e no benefit 26%,
and DNA storage for health Storage given genotyping: 7% don’t feel well 15%,
mental health and research of total sample, 68% of not comfortable/fear 
aging research participants eligible responders 15%, don’t know 11%,
Primary care (n = 342) Storage given genotyping:
patients confidentiality 65%,
Aged ≥ 65 y concern over 
Screened for unknown 27%, don’t 
eligibility onlyb: know 9%, no good 
Black 30%, reason for storage 7%
≥ 80 y 33%
Royal et al. Establish longitudinal cohort Multistate 1, 2, 4, 5, 6, 0.5% of families in total sample, Less education (anecdotal Did not want family to know 
200027 for prostate cancer (n = 8249 7, 8, 1% of families expressing observation) they had cancer, lack
genetic research families) 9, 10 initial interest (n = 3400), of trust of government,
Black 75% of interested and researchers, etc., fear
eligible families (n = 43 of being used as 
reflecting 25% attrition guinea pigs,
rate) researchers do not 
give back to 
community, fear 
misuse of genetic 
information (charged
higher insurance 
premiums), lack of 
immediate or direct 
benefit
Note. Table presents 3 of 14 total studies identified in literature search. Methods: 1 = nonrandom sampling; 2 = primary data collection; 3 = household specimen collection; 4 = actual request;
5 = health care setting/physician request; 6 = other in-person request; 7 = mailed request; 8 = telephone request/follow-up; 9 = Web site request; 10 = other mass media request.
aProportions given when provided by study.
bStatistically significant association found with willingness/consent in bivariate or stratified analysis (α= .05).
cStatistically significant in multivariate regression analysis (α= .05)
dLarger sample demographics not provided.
eOther covariates used in multivariate regression analysis included measures of mental and physical health, and cognitive functioning.
whereas American Indians/
Alaska Natives were not repre-
sented in any of the studies. Six
quantitative studies allowed
comparisons in consent by
racial/ethnic group member-
ship,17,18,21,22,25,26 and only 1
study specified frequencies in
different opinions by racial/
ethnic group membership.28
Finally, 4 studies included for-
mer participants in health17,18,20
or genetic22 research, and
4 studies included participants
personally affected by a genetic
condition.20,22,25,30
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TABLE 4—Descriptive Summary of Studies Regarding US Lay Public Opinions About Genetic Research (n=4)
Benefits of Genetic Research 
Author Year Purpose Samplea and Facilitators to Participationb Concerns and Barriersb
Bates et al. Identify concerns regarding Georgia (n = 91, 9 focus groups) Benefits: Concerns:
200528 genetic research Black, 63%, White 28%, Prevention/treatment of genetic disease: Familial expectations/designer babies: 
Hispanics 9% 82% Whites, 75% Hispanics, 27% Hispanics, 26% Whites, 9% Blacks
Some college/higher 59% 67% Blacks Racial discrimination: 23% Blacks, 23% Hispanics,
Inclusive research protocols: 28% Blacks 10% Whites
Offense to religion: 19% Hispanics, <7% Whites/Blacks
Employment discrimination: 12% Blacks, 12%
Hispanics, 10% Whites
Government/corporate exploitation: 13.6% Whites,
< 9% Blacks/Hispanics
Unequal economic access to benefits: 12% Blacks,
< 9% Whites/Hispanics
Fisher et al. Identify opinions about New York (n = 101, 13 focus Facilitators: Concerns:
200029 ethical issues in groups) Researcher control over how findings are Cannot separate genetic and environmental 
research on genetic 9th–11th graders 54% used by other researchers, influences on teen mental health/behavior
basis of adolescent Parents 46% policymakers, etc. Hard to attribute behavior to specific race given 
risk behaviors and Majority Black, Hispanic, East/ Accurate dissemination of findings mixed heritage
other research South Asian, Multiracial Potential for genetically at risk to be Potential for increased racial prejudice
stigmatized and ostracized Misuse of research by third parties
Premature treatment after diagnosis
Hoyo et al. Identify barriers and North Carolina (n = 55, 5 focus : Facilitators: Barriers:
200330 facilitators of Black groups) Feedback about use of samples and Mistrust of research/medical institutions
male participation in Black research outcomes Lack of disease knowledge
prostate cancer Some college/higher 64% Community gatekeepers and female Extent of involvement (study duration, long surveys,
genetic research Family history cancer 50% partners as recruiters rectal exams culturally inappropriate)
Black investigators and historically Black
college/university involvement
Shorter, more frequent vs long surveys
Specimen collection during routine care
Schulz et al. Identify concerns regarding Michigan (n = 62, 7 focus groups) Benefits: Concerns:
200331 the Human Genome Hispanic 53%, Black 47% Individual- and social-level benefits Disparities in who serves as research subjects vs who 
Project and related College or higher 60% identified by most participants benefits from conducted research
activities Facilitators: Racial discrimination
Wide dissemination of findings Lack of government control over genetic information 
Increased minority involvement as human and technology
subjects, investigators, and advocates
Note. Table presents 4 of 14 total studies identified in literature search.
aAll 4 studies used nonrandom sampling and analyzed primary data from focus groups.
bMost frequently reported by study participants explicitly tied to genetics-related research. Proportions appear when provided by study.
Data Analysis
Studies providing the most de-
tail about consent included fre-
quencies and sociodemographic
information by contact attempt,
successful contact, and con-
sent.22,23 One of these 2 studies
also provided racial/ethnic group
information for the population
from which the sample was
drawn and reasons for non-
response.22 Seven consent stud-
ies included multivariate regres-
sion or stratified analyses to
measure the significance of
sociodemographic, attitudinal/
behavioral, or health status vari-
ables. Three studies included
covariates from all 3 variable cat-
egories. 18,22,25 Thematic analysis
of focus group transcripts were
presented in the 4 qualitative
studies, 1 of which also pre-
sented quantitative data.28
The extent of variation in
study design makes it difficult
to draw strong conclusions
across identified studies. In-




Studies reported public will-
ingness to participate in genetic
research with different mea-
sures of consent, including
overall consent rates (number
providing consent over total
sample), responder consent
rates (number providing consent
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over responders), and eligible re-
sponder consent rates (number
providing consent over eligible
responders). The relative merits
of each for understanding con-
sent are not discussed explicitly
by the authors. However, Royal
et al.27 noted that overall consent
rates can serve as an indicator of
recruitment challenges. In their
study, successful enrollment of
43 families into genetic prostate
cancer research was the result of
more than 8000 initial contacts
with potential participants—an
overall consent rate of 0.5%. By
contrast, the eligible responder
consent rate for their study was
75%, providing information
about participant willingness dur-
ing later stages of recruitment.
Overall consent rates varied
substantially in the 8 studies
that included actual requests for
participation, 5 of which had
overall consent rates below
40%.18,20,22,23,27 Responder con-
sent rates were substantially
higher than overall consent rates,
largely because of reduced de-
nominators.18,21–23,26,27 The high-
est responder consent rates had
majority White American re-
sponders.21–23,26 Reported eligi-
ble responder consent rates21,23,27
were relatively high (>75%).
One of these high consent rates
resulted from an African Ameri-
can sample.27
Study samples that included
people with previous participation
in health or genetic research re-
ported overall consent rates rang-
ing from 21% to 85%.17,18,20,22
Studies in which potential partici-
pants were provided with specific
information about the use of
their DNA also had variable con-
sent rates.18,22,23,26,27 Lastly, stud-
ies that included people with a
personal/familial history of a
genetic condition reported lower
overall consent rates, ranging
from 28% to 53%,20,22,25 the
highest resulting from a hypo-
thetical request.25
Variation of Willingness by
Racial/Ethnic Group
Statistical tests and multivariate
analyses conducted in 6 of the 7
consent studies found racial/
ethnic group membership to be
a significant predictor of consent.
In particular, African American
race was a significant predictor of
lower levels of consent, with only
1 exception.26
Consent among subjects who
had previously participated in
health or genetic research varied
by racial/ethnic group. Moorman
et al.22 found the lowest levels of
consent among former research
participants. In their study, only
37% of African Americans indi-
cated willingness to enroll in a
cancer genetics registry, com-
pared with 58% of White Ameri-
cans. In addition, exclusive or
substantial (41%) African Ameri-
can samples that included people
with personal or familial histo-
ries of a genetic condition also
reported low levels of overall
consent (<37%).20,22
By contrast, Wang et al.25
found that those with a family
history of a genetic condition in a
largely White American sample
reported significantly higher lev-
els of consent. Finally, the high-
est responder consent rates
(>85%) resulted from 2 studies
with largely White American
samples. The first of these 2
studies sampled within a popula-
tion of older primary care pa-
tients18 and the second involved
in-home requests for consent.21
Concerns and Opinions About
Genetic Research
Opinions about genetic re-
search were presented in 7 stud-
ies (Tables 3 and 4). Identifying
concerns was the primary focus
of these studies; however, in 2
studies, the majority of partici-
pants reported benefits to ge-
netic research.28,31 Common
themes appearing across studies
included concerns about dis-
crimination, confidentiality, or
the misuse of information, per-
haps in part because of a lack
of confidence in research-
ers18,27,30,31; perceived dispari-
ties between the participants
and beneficiaries of research31;
and perceptions of being used
by researchers.27 Lack of inter-
est and no perceived benefit
from participation were reported
in several studies as well.18,26,27
This group of concerns is similar
to concerns reported about
medical research.32–34
More specific to genetic re-
search were several concerns in-
cluding the potential for those
at risk of genetic conditions to
be stigmatized and ostracized,29
the initiation of premature treat-
ment,29 changes in familial ex-
pectations or interest in “de-
signer babies,”28 and religious
objections.28 In the only study
that prompted discussion about
research on relations among
race, genes, and health, Fisher
and Wallace29 reported partici-
pant skepticism regarding re-
searchers’ abilities to separate
genetic, environmental, and
racial/ethnic group contribu-
tions to health, particularly in
cases of mixed heritage. Identi-
fied facilitators to participation
in genetic research were often
reflections of reported concerns
(e.g., taking more active control
over the use of research by
third parties29). Finally, although
5 of the 7 studies in Tables 3
and 4 included diverse samples,
only 1 study compared opin-
ions by racial/ethnic group
membership.28
DISCUSSION
We searched for answers to
several questions regarding pub-
lic willingness to participate in
and opinions about genetic vari-
ation research. We expected to
find many more studies given
the substantial controversy sur-
rounding its advancement. Only
1 study in our review provided
insights into the specific con-
cerns people may have regard-
ing participation in genetic
variation research exploring
relations among race, genes,
and health.
Although there were some
patterns by racial/ethnic group
membership regarding consent,
there were few systematic data
across studies that would allow
us to draw strong conclusions
about the relative willingness of




Following are points for con-
sideration in the design of future
studies.
First, it is important to estab-
lish clear distinctions in the liter-
ature among research studies
involving requests for genetic
testing, genetic specimen dona-
tion, or genetic specimen storage.
As discussed previously, the risks
and benefits associated with
these different requests can
vary. Using “genetic research” in
reference to all 3 can obscure
important distinctions. Using a
standard nomenclature when
referencing these different re-
quests and corresponding study
designs will help ensure that
findings regarding consent and
public opinion are placed in their
appropriate context.
Second, to facilitate cross-
study comparisons, future studies
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must include information needed
to calculate overall, responder,
and eligible responder consent
rates, where applicable. Provid-
ing this information by racial/
ethnic group membership, other
sociodemographic variables, and
other characteristics unique to
the study (e.g., health, attitudinal/
behavior indicators) will facilitate
more accurate assessment of con-
sent across studies. Information
on the reasons for nonresponse
is essential to interpret responder
consent rates as well.
Third, researchers conducting
qualitative studies should use ap-
propriate probing techniques to
identify both the benefits and the
concerns participants associate
with genetic research. Consent
studies should include a qualita-
tive component whereby re-
cruited subjects are asked their
reasons for consenting to or de-
clining specific requests. Re-
searchers should build on quali-
tative findings to measure the
extent to which specific or the-
matic opinions are prevalent in
larger diverse samples. When
possible, authors should report
findings by racial/ethnic group
membership.
Fourth, we strongly recom-
mend that future studies explic-
itly ask potential participants
about their willingness to partici-
pate in and their opinions regard-
ing genetic variation research,
highlighting the exploration of
relations among racial/ethnic
group membership, genes, and
health. Our literature review
found only 1 such study. Re-
searchers should make every ef-
fort to include Asian Americans,
Native Americans, Alaskan Na-
tives, and other groups currently
underrepresented.
Finally, to enhance our under-
standing of how the lay public
may perceive genetic variation
research, we encourage investi-
gation into parallel areas of re-
search (some of which already
appear in the literature11,35,36), in-
cluding lay public understandings
of race, ethnicity, genes, and
health and the relations among
them; the extent to which people
hold views consistent with ge-
netic determinism; and opinions
about pharmacogenomics, gene
therapy, and other innovations
that may arise from genetic
research.
Conclusions
Failure to address gaps in this
literature will hinder the scien-
tific and ethical advancement of
genetic research in general, and
genetic variation research in par-
ticular. Incomplete data regard-
ing consent may inaccurately
portray some groups as less will-
ing to participate in genetic re-
search than others. Furthermore,
gaps in information about racial/
ethnic group variation in per-
ceived benefits, concerns, and
other opinions may delay cre-
ative and culturally appropriate
strategies to recruit and retain
human subjects.
We must open the dialogue
occurring within the scientific
community about the use of ra-
cial/ethic group membership in
genetic variation research to
members of the general public
who may serve as future study
participants. As demonstrated
by Fisher and Wallace29 and
others conducting parallel areas
of research, the public can en-
gage in meaningful dialogue
about these issues and should
be provided with more opportu-
nities to do so.
POSTSCRIPT
During production of this arti-
cle, 4 new studies satisfying the
inclusion criteria for this review
came to the authors’ attention
via the Centers for Disease Con-
trol and Prevention Genomics
and Health Weekly Update
(http://www.cdc.gov/genomics/
update/current.htm).37–40 Of
note, Buchwald et al.37 reported
consent rates for participation
in a hypothetical genetic study
among 420 urban American 
Indian/Alaska Native patients
and staff at an Indian health care
facility. Associations between
consent and different study char-
acteristics (i.e., subject matter,
risks and benefits, institutional
sponsor, community involve-
ment) also were reported.
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